Skip to search formSkip to main content

DD-723

 
National Institutes of Health

Related topics

Related topics

1 relation
Sonazoid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Phase II clinical study of DD-723 (perflubutane): dose–response study in patients with breast tumors
PurposeWe compared the contrast effect of three doses of DD-723 in subjects with breast tumors to determine the recommended dose… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2006
2006
2235: Detection of focal liver lesions with a next generation ultrasound contrast agent, DD-723 (NC100100)
 
Is this relevant?
2005
2005
The effects of Levovist and DD-723 in activating platelets and damaging hepatic cells of rats.
OBJECTIVE The purpose of this study was to compare platelet activation and hepatic cell damage produced by 2 ultrasonographic… Expand
Is this relevant?
2004
2004
Comparison of platelet activation and hepatic cell damage of rats induced by two ultrasound contrast agents
Abstract We compared the platelet activation and rat hepatic cell of damage induced by two ultrasound contrast agents. Two… Expand
Is this relevant?
2000
2000
Contrast harmonic imaging of the liver using a novel ultrasound contrast agent, DD-723 (NC100100)-phase 1 clinical trial
 
Is this relevant?
2000
2000
超音波造影剤 DD-723 (NC100100) による肝臓の造影ハーモニックイメージング-第1相臨床試験の造影効果について-
 
Is this relevant?